Beactica Therapeutics AB
Share:
Subscribe:
news.cision.com
/
Beactica Therapeutics AB
/
Beactica Therapeutics appoints Head of Chemistry and two new members to its Board of Directors to strengthen its strategic focus on cancer
/
Ted Fjällman
2 of 3
Ted Fjällman
Tue, Sep 14, 2021 08:00 CET
Low resolution
Medium resolution
Original resolution
Subscribe
